Why is Zim Laboratories falling/rising?

As of 23-Sep, Zim Laboratories Ltd is currently priced at 75.60, reflecting a slight increase of 0.02 or 0.03%. The stock has shown a performance today that outperformed its sector by 0.38%, indicating a potential trend reversal after three consecutive days of decline. However, despite this minor uptick, the stock has experienced significant underperformance over the past year, with a return of -31.37%. The company's financial health is concerning, as it has reported a decline in profits by -47.6% and has declared negative results for the last five consecutive quarters. The stock is trading at a discount compared to its peers, but its weak long-term fundamentals, including a low Return on Capital Employed (ROCE) of 6.5%, suggest ongoing challenges.
In the broader market context, Zim Laboratories' short-term return of +0.56% over the past week contrasts with the Sensex, which has declined by -0.34%. While the stock has managed to gain slightly in the short term, its long-term performance remains troubling, with a staggering -67.57% drop over the last three years compared to a +41.31% increase in the benchmark. This consistent underperformance against the benchmark, coupled with falling investor participation and liquidity concerns, indicates that while there may be short-term fluctuations, the overall outlook for Zim Laboratories remains weak.